Recruiting

ECG Sensor

Sponsor:

Northwestern Medicine

Code:

NCT04341506

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Non-contact ECG

Study Details

Brief summary:

The purpose of this study is two-fold. First we would like to confirm that non-contact ECG provides equivalency to current contact methods of obtaining ECG data. Second we would like to investigate whether non-contact ECG can detect ECG changes prior to the onset symptoms from COVID19.

Conditions

COVID-19

Study ID

NCT04341506

Start date

Sep 8, 2020

Status verified date

Sep, 2020

Completion date

Dec 15, 2021

Anticipated

Primary completion date

Jul 15, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Any employee of Lake Forrest Memorial Hospital presenting to work
  • Age greater than 18 years-old

Exclusion Criteria:

  • Age less than 18 years-old
  • Non-employee

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Arms

Participant ECG

The study has one arm, I.e., we will collect daily ECGs in 100 participants and track their ECG over three months. We will then compare ECGs pre and post COVID-19 diagnosis in any participant diagnosed with COVID-19 to assess for any early ECG changes that may aid with diagnosing.

Interventions

Non-contact ECG

A non-contact ECG will be used to detect a patient cardiac electrical activity.

Primary outcome measure

  • ECG changes associated with COVID-19 [ Time Frame: 3 months ]

Central Contacts and Locations

Central contacts

Andrew Gostine, MD

(312) 695-0061andrew.gostine@nm.org

Locations

Northwestern Medicine

Recruiting

Chicago, Illinois, United States, 60610

More Information

Sponsor

Northwestern Medicine

Last update posted

Sep 9, 2020

Last verified

Sep, 2020

Keywords

  • COVID-19
  • ECG
  • Arrhythmia

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Northwestern Medicine on 2020-09-09.